95252 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Indazoles and use thereof
#3302Cycloalkane derivatives
#3303Aminotriazole-based KDM1A inhibitors as epigenetic modulators
#3304Somatostatin modulators and uses thereof
#3305Substituted biphenyl analogues as dual inhibitors of aromatase and sulfatase
#3306Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
#3307Carboxamide derivatives
#3308Sunless tanning compounds and compositions
#3309Imidazotriazine derivatives as modulators of TNF activity
#3310Anti-alphavbeta1 integrin compounds and methods
#33116 Phenyl or 6 Pyridin 3 YL Indazole Derivatives and Methods of Use
#3312Kinase inhibitors
#3313Methods and compositions associated with the granulocyte colony-stimulating factor receptor
#3314COMPOUNDS AND METHODS FOR DETECTION AND ISOLATION OF BIOMOLECULES
#3315Syk inhibitors
#3316Plant growth regulating compounds
#3317DNA-PK inhibitors for treatment of cancer
#3318Therapeutic compounds
#3319Pharmaceutical compound
#3320Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
#3321Fused heterocyclic compounds as ion channel modulators
#3322Pyrimidine compounds containing seven-membered fused ring systems
#3323Amide compounds for treatment of complement mediated disorders
#3324Quinazolines as potassium ion channel inhibitors
#3325ENDOPARASITE CONTROL AGENT
#3326Pro-neurogenic compounds
#3327PRO-NEUROGENIC COMPOUNDS
#3328COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#3329Pharmaceutical compounds
#3330Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#3331Polycyclic estrogen receptor modulators and uses thereof
#3332NOVEL COMPOUNDS
#3333Inhibitors of Bruton's tyrosine kinase
#3334Triazoles for the treatment of Demyelinating Diseases
#3335Benzimidazole derivatives as selective blockers of persistent sodium current
#3336Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
#3337Inhibitors of histone deacetylase
#3338Bicyclic-fused heteroaryl or aryl compounds
#3339Benzamide and nicotinamide compounds and methods of using same
#3340Tetrasubstituted alkene compounds and their use
#3341Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)
#3342Pyrazoles for controlling invertebrate pests
#3343Kinase inhibitors
#3344Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
#3345Substituted benzooxadiazole DNA-PK inhibitors
#3346Herbicidal substituted pyrimidinyloxy benzene compounds
#3347Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors
#3348Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
#3349TETRACYCLIC COMPOUND
#3350Radiolabeled tracers for poly (ADP-ribose) polymerase-1 (PARP-1), methods and uses therefor
#3351Heterocyclic carboxamides as modulators of kinase activity
#3352Triazolone compounds as mPGES-1 inhibitors
#3353Benzimidazole and imadazopyridine carboximidamide compounds
#3354Pyrimidinyloxy benzene derivatives as herbicides
#3355Modulators of ATP-binding cassette transporters
#3356Hepatitis B antiviral agents
#3357Mutant-selective EGFR inhibitors and uses thereof
#3358Diaminopyrimidine benzenesulfone derivatives and uses thereof
#3359Pyrimidines and use thereof
#3360Pyrazolyl pyrimidinamine compound and application thereof
#3361Indole compound
#3362Fused imidazole compounds
#3363Heterocyclic compounds useful as PDK1 inhibitors
#3364Methacrylamide compounds
#3365Tricyclic sulfones as RORγ modulators
#3366Substituted 6,5-fused bicyclic heteroaryl compounds
#3367BICARBOCYCLIC AND TRICARBOCYCLIC ETHYNYL DERIVATIVES AND USES OF SAME
#3368PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
#3369Pyridazine compounds, compositions and methods
#3370PYRROLIDINYL SULFONE DERIVATIVES AND THEIR USE AS ROR GAMMA MODULATORS
#3371Reversible pegylated drugs
#3372Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
#3373Urea derivatives useful as kinase inhibitors
#3374Nrf2 regulators
#3375Kinase inhibitors
#3376Compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor
#3377Methods to treat lymphoplasmacytic lymphoma
#33784-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors
#3379Allosteric modulators of factor XIa as anticoagulant agents
#3380Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments
#3381Biaryl inhibitors of Bruton's tyrosine kinase
#3382Indazole compounds as 5-HTreceptor agonists
#3383N-arylmethyl sulfonamide negative modulators of NR2A
#3384Substituted indazole derivatives active as kinase inhibitiors
#3385Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
#3386Compounds as TNIK, IKKε and TBK1 inhibitors and pharmaceutical composition comprising same
#3387Substituted indazole derivatives active as kinase inhibitiors
#3388Compositions and methods for treating respiratory injury or disease
#3389PSMA imaging agents
#3390Compounds, compositions and methods for inhibiting CNKSR1
#3391Inhibitors of lysine specific demethylase-1
#3392Compound having higher inhibitory activity on protein kinase G and preparation method thereof
#3393Methods of promoting wound healing using CRM1 inhibitors
#3394Hydrazide containing nuclear transport modulators and uses thereof
#3395Certain chemical entities, compositions, and methods
#33962-thiopyrimidinones
#3397NOVEL COMPOUNDS AS JNK KINASE INHIBITORS
#33983-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#3399APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#3400ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
#3401Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
#3402Chromene derivatives as phoshoinositide 3-kinases inhibitors
#3403Substituted 2,4-diaminopyrimidines as kinase inhibitors
#3404Substituted amino triazoles, and methods using same
#3405Viral replication inhibitors
#3406Substituted 1H-indazol-1-OL analogs as inhibitors of beta catenin/Tcf protein-protein interactions
#3407Dihydropyrazole GPR40 modulators
#3408Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#3409Substituted quinazoline compounds and methods of use thereof
#3410S1P3 antagonists
#3411Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#3412Polysubstituted pyrroles having microtubule-disrupting, cytotoxic and antitumor activities and methods of use thereof
#3413Pyrrolidinones as herbicides
#3414N-substituted benzamides and methods of use thereof
#3415Aminoquinazoline and pyridopyrimidine derivatives
#3416Hepatitis B antiviral agents
#3417TRPV1 Vanilloid Receptor Antagonists With A Bicyclic Portion
#3418Pyrazole derivatives as TNIK, IKKϵ and TBK1 inhibitor and pharmaceutical composition comprising same
#3419FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES III
#3420Substituted pyridazines for the treatment of pain
#3421SUBSTITUTED PHENYLALANINE DERIVATIVES
#3422N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#3423Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
#3424Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
#3425SUBSTITUTED PHENYLALANINE DERIVATIVES
#3426N-pyrrolidinyl,N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#3427P2X4 receptor antagonist
#3428Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents
#3429Dihydropyrazole GPR40 modulators
#3430N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
#3431Zwitterionic reagents
#3432Pro-drugs of NSAIAs with very high skin and membranes penetration rates and their new medicinal uses
#3433SUBSTITUTED PHENYLALANINE DERIVATIVES
#3434Tetrahydro-benzodiazepinones
#3435Quinazolinone and isoquinolinone derivative
#3436N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#3437N-alkyl lactam ethers, and compositions and uses thereof
#3438Modulators of ATP-binding cassette transporters
#3439Tetrazolinone compound and use thereof
#3440Substituted benzamides
#3441Substituted sulfonamide compounds
#3442Anti-alphavbeta1 integrin inhibitors and methods of use
#3443Quinazoline derivative
#3444Heteroaryl compounds as BTK inhibitors and uses thereof
#3445HETEROCYCLIC COMPOUND
#3446Substituted azines as pesticides
#3447Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)
#3448Cannabinoid receptor mediating compounds
#3449Benzazepine dicarboxamide compounds
#3450Alkylene derivatives
#3451NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES
#3452Methods and intermediates for preparing macrolactams
#3453Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors
#3454Inhibitors of histone deacetylase
#3455Aromatic heterocyclic compounds and their application in pharmaceuticals
#3456Carboxylic acid compounds
#3457Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#3458Quinazoline compounds
#3459Aurora kinase inhibitors
#3460Tetrazolinone compound and use thereof
#3461Compounds for inhibiting cell proliferation in EGFR-driven cancers
#3462Sulfonamide derivative and pharmaceutical use thereof
#3463Heteroaryl Syk inhibitors
#3464SUBSTITUTED PHENYLALANINE DERIVATIVES
#3465Substituted piperazine compounds and methods of use thereof
#3466Substituted uracils as chymase inhibitors
#3467Pyridazinone and pyridone compounds
#3468Labeled pkg-1-alpha-binding compounds and their use in imaging and quantifying pain
#3469Method of synthesizing thyroid hormone analogs and polymorphs thereof
#3470Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
#3471Therapeutic compounds and uses thereof
#34721-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof
#3473SUBSTITUTED PHENYLALANINE DERIVATIVES
#3474Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmetics
#3475THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING ALLOSTERIC KINASE INHIBITION
#3476HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE
#3477SUBSTITUTED PHENYLALANINE DERIVATIVES
#3478KDM1A inhibitors for the treatment of disease
#3479Benzathine analogs
#3480Therapeutic compounds and uses thereof
#3481FBXO3 inhibitors
#3482Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
#3483Tetrazolinone compound and use thereof
#3484Kinase inhibitors
#3485TrkA kinase inhibitors, compositions and methods thereof
#3486Multivalent RAS binding compounds
#3487Cyanotriazole compounds
#3488Heterocyclic compounds for the inhibition of PASK
#3489Heterocyclic compound
#3490GLP-1 receptor modulators
#3491Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use
#3492Methods for treating cancer with TrkA receptor tyrosine kinase antagonists
#3493Chemokine receptor binding heterocyclic compounds with enhanced efficacy
#3494Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders
#3495Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death
#3496Heterocyclic compounds and uses thereof
#3497DENDRITIC COMPOUNDS INCLUDING A CHELATING, FLUOROCHROME OR RECOGNITION AGENT, COMPOSITIONS INCLUDING SAME AND USES THEREOF
#3498Pyridazinone compounds and uses thereof
#3499Sulfonylindole derivatives and method for preparing the same
#3500SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS
#3501Substituted quinoxalines as FGFR kinase inhibitors
#3502Charge control agent and toner using same
#3503GLP-1 receptor modulators
#3504Quinazoline derivative and preparation method therefor
#3505EBI2 modulators
#3506Autotaxin inhibitor compounds
#3507Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis
#3508Tetrazolones as a carboxylic acid bioisosteres
#3509Active light sensitive or radiation sensitive resin composition, active light sensitive or radiation sensitive film, mask blank provided with active light sensitive or radiation sensitive film, pattern forming method, method for manufacturing electronic device, electronic device and novel compound
#3510Liquid crystal composition containing nitrogen-containing cyclic compound and liquid crystal display device
#3511Synthesis of cross-linked plant-oil based polymers using bismaleimides as crosslinkers
#3512Heteroaryl amides as inhibitors of protein aggregation
#3513Substituted pyrimidine compounds, compositions and medicinal applications thereof
#3514Apelin receptor (APJ) agonists and uses thereof
#3515Anti-depression compounds
#3516Pro-neurogenic compounds
#3517Tetrazolinone compound and use of same
#3518Carbazole-containing sulfonamides as cryptochrome modulators
#3519Cinnoline derivatives useful as CB-1 receptor inverse agonists
#3520Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
#3521Heteroaromatic compounds and their use as dopamine D1 ligands
#3522Indole compound as inhibitor of necrosis
#3523Benzimidazolyl-methyl urea derivatives as ALX receptor agonists
#3524Tetrahydrocyclopentapyrrole derivatives and a method for preparing the same
#3525IDO inhibitors
#3526Carbazole derivative, light-emitting element material, light-emitting element, light-emitting device, electronic device, and lighting device
#3527Indole amide compound as inhibitor of necrosis
#3528Styryl quinazoline derivatives as pharmaceutically active agents
#3529Anti-malarial agents
#3530Quinazolinones as bromodomain inhibitors
#3531Diazole amides
#3532Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
#3533N-alkoxyamide conjugates as imaging agents
#3534Triazine derivative and pharmaceutical composition comprising the same
#3535Anthelmintic compounds and compositions and method of using thereof
#3536Autotaxin inhibitors
#3537Aminopyrimidine derivatives for use as modulators of kinase activity
#3538Heterocyclyl pyrimidine analogues as TYK2 inhibitors
#3539Tetrazolinone compounds and their use as pesticides
#3540SUBSTITUTED PYRIDAZINE CARBOXAMIDE COMPOUNDS AS KINASE INHIBITOR COMPOUNDS
#3541Process for making beta 3 agonists and intermediates
#3542Spirocyclic EBI2 modulators
#35433,5-diaminopyrazole kinase inhibitors
#3544N-cyanomethylamides as inhibitors of janus kinase
#3545Kinase inhibitors for the treatment of disease
#3546Tetrazolinone compound and use thereof
#3547Quinazoline derivatives, compositions thereof, and use as pharmaceuticals
#3548AUTOTAXIN INHIBITORS
#3549Chemical compounds
#3550Crosslinking reagents, methods, and compositions for studying protein-protein interactions
#3551Benzimidazole-2-piperazine heterocyclic compound, pharmaceutical composition containing the same, preparation method and use thereof
#3552Tetrazolinone compound and use thereof
#3553Compounds for treatment of cystic fibrosis
#3554Quinazolines as biogenic amine transport modulators
#3555Covalent inhibitors of K-Ras G12C
#3556N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
#35572,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
#3558Chemical compounds
#35594- and 5-substituted 1,2,3-triazole, and regioisomer mixtures thereof, modified polymers
#3560HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#3561PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#3562Inhibitors of lysine specific demethylase-1
#3563AKT PROTEIN KINASE INHIBITORS
#3564Tetrazolinone compounds and applications thereof
#3565Nuclear transport modulators and uses thereof
#3566Novel Anti-Cancer Agents
#3567Protein tyrosine kinase modulators and methods of use
#3568Nitrogen-containing saturated heterocyclic compound
#3569Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
#3570Materials for electronic devices
#3571Heteroaryl inhibitors of PDE4
#3572TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF
#3573Bicyclic sulfonamide compounds as sodium channel inhibitors
#3574PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES
#3575PRMT5 inhibitors and uses thereof
#3576Anti-inflammatory agents
#3577Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
#3578Pyrimidine compounds as mTOR and PI3K inhibitors
#3579Medicaments for the treatment or prevention of fibrotic diseases
#3580SURFACTANTS WITH A TERMINAL DIALKYL- OR CYCLOALKYL-SUBSTITUTED TERTIARY AMINE AND INKS INCLUDING THE SAME
#3581GLYCINE TRANSPORTER INHIBITOR
#3582Pyrazole p38 map kinase inhibitors
#3583Inhibitors of lysine specific demethylase-1
#3584Pyrimidine FGFR4 inhibitors
#35854-alkynyl imidazole derivative and medicine comprising same as active ingredient
#3586Substituted quinazolines as receptor-type kinase inhibitors
#3587Pyrimidine compounds and their use as gamma secretase modulators
#3588Inhibitors of equilibrative nucleoside transporter type I as anti-parasitic compounds
#3589Pyrimidine compounds as kinase inhibitors
#3590Isoindoline inhibitors of ROR-gamma
#3591Phenyl triazole derivative and its use for modulating the GABAreceptor complex
#3592Lanthionine synthetase C-like 2-based therapeutics
#3593COMPOUNDS, COMPOSITIONS COMPRSING SAME, AND METHODS RELATED THERETO
#3594Indole carboxamide compounds
#3595Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
#3596Inhibitors of lysine specific demethylase-1
#3597Compound
#3598Triazole compounds and their use as gamma secretase modulators
#3599CXCR7 receptor modulators
#3600Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof